Fluasterone, formerly known as HE2500, is an NF-κB activation inhibitor potentially for the treatment of metabolic syndrome. References: Burgess JP, Green JS, Hill JM, Zhan Q, Lindeblad M, Lyubimov A, Kapetanovic IM, Schwartz A, Thomas BF. Identification of [14C]fluasterone metabolites in urine and feces collected from dogs after subcutaneous and oral administration of [14C]fluasterone. Drug Metab Dispos. 2009 May;37(5):1089-97. doi: 10.1124/dmd.108.023614. PubMed PMID: 19196848; PubMed Central PMCID: PMC2683393.

纯度：≥98%

CAS：112859-71-9